J&J in discussions with Indian Govt single dose vaccine trial

The company’s vaccine is currently approved for use in the US, the European Union and other nations including Thailand and South Africa.

100
Clinical Trial Research
Clinical Trial

Last Updated on December 31, 2023 by The Health Master

Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose C-19 vaccine in the country, the company said on Friday.

The company’s vaccine is currently approved for use in the US, the European Union and other nations including Thailand and South Africa.

The news comes as some parts of India face a shortage of vaccine supplies just as the country of 1.3 billion battles the second wave of C-19 infections. India’s government, however, has said there is no shortage of shots.

Laboratory
Picture: Pixabay

The Indian Express newspaper reported earlier that J&J had sent a letter to India’s Central Drugs Standard Control Organisation (CDSCO) saying it would “very shortly apply for permission to conduct clinical bridging trials in India”.

The CDSCO did not immediately respond to Reuters request for comment.

“We are in discussions with the (government) with the objective of starting a bridging clinical study of our Janssen C-19 vaccine candidate in India, subject to local regulatory approvals,” a local J&J representative said via email.


To read more articles about J&J, click here


A bridging study tests the safety and immunogenicity of a vaccine, and India has indicated that any vaccine maker must conduct such a trial for a shot to be considered for its immunisation programme.

Separately, J&J has a deal with Indian firm Biological E to contract-manufacture its vaccine.

India currently has two approved vaccines in use, one developed by Oxford University and AstraZeneca and the other, a shot from local player Bharat Biotech.

There are other vaccine candidates in trials in India including Russia’s Sputnik-V and a shot developed by Cadila Healthcare.


Also read:

IPC invites bids for supply of Ref Std, Impurities from Pharma…

Govt to pharma firms: Ramp up Remdesivir Mfg to full capacity

Samsung turns smartphones into Medical Diagnosis cameras

Aleor gets tentative USFDA nod for drug for topical treatment

Zydus Cadila gets final USFDA nod for drug to treat High…

NABH extended validity of accreditation for Hospitals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news